Company Profile For Grifols, S.A.

Grifols, S.A. (GRLS.MC) (Madrid SE C.A.T.S.)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  4 Dec 2009
11.52EUR
Price Change
+0.20
Percent Change
+1.77%
 
 
Research a stock:   symbol lookup

Overview

Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of plasma derivates, IV therapy, enteral nutrition, diagnostic systems and medical materials. It operates through three areas: bioscience, diagnostic and hospital. In the bioscience area, the Company is engaged in the research, development, production and commercialization of plasma derivates. In the diagnostic area, it is involved in the research, development, manufacturing and marketing of diagnostic products for laboratory analysis, including products for hospital blood banks and transfusion centers. In the hospital area, it provides non-biological products used in hospital pharmacies, surgery, nutritional support and fluid therapy, among others.

Quick Financial Synopsis

BRIEF: For the six months ended 30 June 2009, Grifols SA's total revenue increased 16% to EUR473.2M. Net income for the period increased 31% to EUR81.7M. Total revenue reflects an increase in sales in all business segments, mainly in the United States and all other markets. Net income for the period benefited from increased financial income, the presence of income from foreign exchange operations as well as lower financial costs.

Company Address

Grifols, S.A.
Torre Mapfre - Planta 26
c/ Marina 16-18
Barcelona   BAR   08005
P: +34935.710500
F: +34935.710267

Total Employees

5926

Find Out More About GRLS.MC

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement